fool.com·Apr 12, 2026
Amid struggles in the tech sector, investors are reassessing their portfolios, with healthcare stocks like Johnson & Johnson and Pfizer gaining attention as they have performed well this year while the S&P 500 has declined. This shift highlights the potential for continued momentum in the pharmaceutical sector.
Consider reallocating part of your portfolio to the healthcare sector, particularly in pharmaceutical stocks like Johnson & Johnson and Pfizer, which have shown resilience and growth this year despite the broader market's decline. This sector may offer a hedge against volatility in tech and could benefit from increased demand and stability.